ReVision Implant
Develops a bionic vision implant designed to restore sight by transmitting visual signals directly to the brain.
Overview
ReVision Implant is developing a bionic eye system for vision restoration, centered on a device that feeds visual information directly into the brain. The company operates in neuroprosthetics and deep tech, targeting medical applications for people with severe vision loss. Its key differentiator is a brain-direct vision interface, positioning it within advanced implantable device development rather than conventional assistive vision tools. ReVision Implant raised €4M in an undisclosed round announced in May 2026.
Funding History
The bionic eye: ReVision Implant lands €4M for a vision device that feeds directly into your brain
Frequently Asked Questions
- How much funding does AI Funding track for ReVision Implant?
- AI Funding tracks €4M for ReVision Implant across 1 funding round in this database.
- What does ReVision Implant do?
- ReVision Implant is developing a bionic eye system for vision restoration, centered on a device that feeds visual information directly into the brain. The company operates in neuroprosthetics and deep tech, targeting medical applications for people with severe vision loss. Its key differentiator is a brain-direct vision interface, positioning it within advanced implantable device development rather than conventional assistive vision tools. ReVision Implant raised €4M in an undisclosed round announced in May 2026.
- Where is ReVision Implant headquartered?
- ReVision Implant is headquartered in San Francisco, CA.
Related Insights
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
Track 395+ AI funding rounds—investors, valuations, and deal sizes from pre-seed to IPO. Updated daily so you never miss a round.
An in-depth look at how AI-focused venture capital operates — from fund structure and deal sourcing to due diligence, portfolio management, and exit strategies in the AI era.